Biodesix (BDSX) Notes Payables (2019 - 2025)
Historic Notes Payables for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $11000.0.
- Biodesix's Notes Payables fell 6206.9% to $11000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11000.0, marking a year-over-year decrease of 6206.9%. This contributed to the annual value of $21000.0 for FY2024, which is 5882.35% down from last year.
- Latest data reveals that Biodesix reported Notes Payables of $11000.0 as of Q3 2025, which was down 6206.9% from $16000.0 recorded in Q2 2025.
- Biodesix's 5-year Notes Payables high stood at $14.3 million for Q3 2022, and its period low was $11000.0 during Q3 2025.
- Moreover, its 5-year median value for Notes Payables was $49000.0 (2022), whereas its average is $1.7 million.
- As far as peak fluctuations go, Biodesix's Notes Payables plummeted by 9992.48% in 2021, and later surged by 7157000.0% in 2022.
- Over the past 5 years, Biodesix's Notes Payables (Quarter) stood at $19000.0 in 2021, then surged by 157.89% to $49000.0 in 2022, then grew by 4.08% to $51000.0 in 2023, then crashed by 58.82% to $21000.0 in 2024, then plummeted by 47.62% to $11000.0 in 2025.
- Its Notes Payables stands at $11000.0 for Q3 2025, versus $16000.0 for Q2 2025 and $18000.0 for Q1 2025.